Shen Mi, member of the Standing Committee of CPC Suzhou Committee and secretary of CPC SIP Working Committee, met with Mojdeh Poul, president and CEO of Integra LifeSciences, and her contingent in SIP on Sept 15.

Integra LifeSciences is a global leader in medical technology with headquarters in Princeton, New Jersey, the United States. The company established in SIP its first integrated manufacturing and testing facility in China in 2023, and added an investment of US$ 20 million late last year to expand the facility, planning to expand its business in the country over the following five years.

During the meeting, Shen Mi extended welcome to the guests and expressed thanks for Integra LifeSciences’ trust and continuous investment. He gave the guests a specific introduction to SIP’s advantages in bolstering businesses engaged in biomedicine and healthcare, and policies offered by governments at different levels for multinationals seeking development in China. He hoped Integra LifeSciences would bring more advanced products, technologies and resources into SIP in the future.

Mojdeh Poul expressed gratitude to SIP for its support for Integra LifeSciences’ projects, saying that Integra LifeSciences would like to deepen cooperation with SIP in progressing the projects and make contributions to local economic growth and global medical technology advancement.

September 16, 2025